La. Appeals Court Backs Novartis In Schizophrenia Drug Suit

Law360, New York (June 17, 2015, 10:09 PM EDT) -- A Louisiana state appeals court on Wednesday reversed a lower court's judgment against Novartis Pharmaceutical Corp. in an injury suit over the allegedly serious side effects of its schizophrenia medication Clorazil that a Louisiana man had claimed caused seizures. 

The Louisiana Court of Appeal for the Fourth circuit reversed a lower court's decision to grant a partial summary judgment motion by plaintiff Wayland Ezeb, who had argued that an earlier summary judgment decision in the dispute had established certain facts about Novartis' purported liability. 

Ezeb's suit...
To view the full article, register now.